SPY389.58+9.22 2.42%
DIA315.59+6.14 1.98%
IXIC13,588.83+396.48 3.01%

DJ Correction to AstraZeneca Vaccine Effective Against U.K. Covid-19 Variant in Trial Article

· 02/05/2021 17:05

Researchers in the study examined nose and throat swabs. "AstraZeneca Vaccine Effective Against U.K. Covid-19 Variant in Trial" at 9:27 a.m. and 11:56 a.m. ET, incorrectly said they looked at blood samples.

(END) Dow Jones Newswires

February 05, 2021 17:05 ET (22:05 GMT)

Copyright (c) 2021 Dow Jones & Company, Inc.